Shield Therapeutics plc (LON:STX – Get Free Report)’s share price shot up 11.5% during trading on Friday . The stock traded as high as GBX 4.80 ($0.06) and last traded at GBX 4.79 ($0.06). 1,228,729 shares were traded during mid-day trading, a decline of 75% from the average session volume of 4,819,253 shares. The stock had previously closed at GBX 4.30 ($0.06).
Shield Therapeutics Stock Up 9.3 %
The stock has a market capitalization of £36.76 million, a PE ratio of -117.50 and a beta of 1.42. The company has a current ratio of 1.05, a quick ratio of 2.16 and a debt-to-equity ratio of 3,691.50. The company’s 50-day moving average is GBX 4.15 and its 200 day moving average is GBX 2.63.
About Shield Therapeutics
Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.
Featured Stories
- Five stocks we like better than Shield Therapeutics
- What is the S&P/TSX Index?
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- What is the Hang Seng index?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Shield Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shield Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
